Emtricitabine Capsule
Product Images NDC 65862-301

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Emtricitabine (NDC 65862-301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Emtricitabine Fig1)

Pharmacokinetic curve depicting Emtricitabine concentration (µg/mL) in the blood over a 24-hour period following administration. The x-axis represents time in hours, and the y-axis shows drug concentration on a logarithmic scale. The graph includes a peak concentration reached around 2 hours post-dose, followed by a gradual decline.*

FDA Label Image

Package Label.principal Display Panel (200 mg(30 Capsule Bottle))

Label for Emtricitabine Capsules 200 mg by Aurobindo Pharma Limited, listing 30 capsules per container. The label includes storage instructions, distributor information (Aurobindo Pharma USA, Inc.), and a barcode. It emphasizes the product as prescription-only with dosage directions on the package insert.*

FDA Label Image

Figure1 (Emtricitabine Str)

Chemical structure of Emtricitabine, depicting its molecular framework including nitrogen, oxygen, fluorine atoms, and a thiofuranose moiety as part of its structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.